首页> 外国专利> TREATMENT OF SUBARACHNOID HEMATOMA USING SONOTHROMBOLYSIS AND ASSOCIATED DEVICES, SYSTEMS AND METHODS

TREATMENT OF SUBARACHNOID HEMATOMA USING SONOTHROMBOLYSIS AND ASSOCIATED DEVICES, SYSTEMS AND METHODS

机译:超声溶血及相关装置,系统和方法治疗蛛网膜下腔血肿

摘要

Methods for treating a human patient having a subarachnoid hematoma, such as to prevent cerebral vasospasm or to reduce the severity of cerebral vasospasm in the patient, and associated devices, systems, and methods are disclosed herein. In a particular embodiment, a thrombolytic agent is introduced extravascularly into a subarachnoid region including the hematoma. A headset configured for hands-free delivery of transcranial ultrasound energy is connected to the patient and used to deliver ultrasound energy to the subarachnoid region to enhance the thrombolytic effect of the thrombolytic agent. The type and/or dosage of the thrombolytic agent can be selected based on the enhanced thrombolytic effect. For example, the enhanced thrombolytic effect can allow the therapeutically effective use of less aggressive thrombolytic agents and/or lower dosages of thrombolytic agents. In some cases, this can reduce the clinical probability of additional cerebral hemorrhage.
机译:本文公开了用于治疗患有蛛网膜下腔血肿的人类患者的方法,以预防患者的脑血管痉挛或减轻脑血管痉挛的严重程度,以及相关的装置,系统和方法。在一个特定的实施方案中,将血栓溶解剂通过血管外引入包括血肿在内的蛛网膜下腔区域。配置用于免提传递经颅超声能量的头戴式耳机与患者连接,并用于将超声能量传递到蛛网膜下腔区域,以增强溶栓剂的溶栓作用。可以基于增强的溶栓作用选择溶栓剂的类型和/或剂量。例如,增强的溶栓作用可以允许治疗上有效地使用侵略性较小的溶栓剂和/或较低剂量的溶栓剂。在某些情况下,这可以减少其他脑出血的临床可能性。

著录项

  • 公开/公告号US2018154187A1

    专利类型

  • 公开/公告日2018-06-07

    原文格式PDF

  • 申请/专利权人 DAVID W. NEWELL;

    申请/专利号US201715803702

  • 发明设计人 DAVID W. NEWELL;

    申请日2017-11-03

  • 分类号A61N7/02;A61B17/22;A61B90/10;A61N7/00;A61B8/08;A61B8/06;

  • 国家 US

  • 入库时间 2022-08-21 13:01:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号